An FDA draft guidance nixing the requirement for biosimilar manufacturers to conduct comparative efficacy studies may prove ...
The U.S. Food and Drug Administration (FDA) announced a new process called “Rare Disease Evidence Principles” (RDEP), under which eligible drugs and biologics for ultra-rare diseases caused by known ...
10hon MSN
Takeaways from the AP's report on turmoil surrounding the FDA's new fast-track drug program
A plan to slash drug review times at the Food and Drug Administration is sparking deep concerns among agency staffers and ...
The U.S. Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to ...
A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...
Drugmakers told the FDA that inflexible post-approval change requirements are among the top regulatory barriers to the ...
The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...
1don MSN
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...
A senior Food and Drug Administration official on Friday said the agency will change its vaccine approval process, alleging that COVID-19 vaccination resulted in the deaths of 10 children.Video above: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results